China's Sinovac Biotech vaccine is 98% effective at preventing death and 96% effective at preventing hospitalisation, a Indonesian study on health workers reportedly showed.
The controversial Chinese shot, however, performed far worse than western vaccines in clinical trials.
The preliminary study was done from data on healthcare workers in the Indonesian capital Jakarta who had received the CoronaVac vaccine between January and March this year.